• About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure
  • About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure
TECHNOLOGY TRANSFER

Innovator Profile

Headshot of Melissa Reynolds.

Melissa Reynolds, PhD

Professor, Department of Chemistry

Primary College

  • College of Natural Sciences

Innovator Links

  • Google Scholar
  • PubMed
  • Faculty Profile
  • Other

Innovator Bio

Our research is multidisciplinary and focuses on the molecular design and fabrication of biomimetic materials for use in medical device applications. Biomedical materials development includes the synthesis of prodrugs to simultaneously detect and kill bacteria, glucose biosensing, fabrication of biomass-sourced and biodegradable nitric oxide (NO) releasing polymers, the creation of new pediatric cancer therapeutics, and the creation of new materials to improve extracorporeal membrane oxygenation (ECMO). Our metal-organic frameworks (MOF) research includes the development of next-generation glucose biosensing, fluorescence-based sensing of heavy metals, incorporation of MOFs into biocompatible medical devices, and MOF-based high-performance liquid chromatography (HPLC) separations. Fundamental areas of MOF research include thermal/materials analysis of MOF catalysts, development of flow catalysis systems with MOFs, and kinetic/mechanistic investigations into MOF biocatalysis. Current projects related to analytical method development include generation of liquid chromatography-mass spectrometry (LC-MS) separation and detection methods to analyze the safety and biocompatibility of biodegradable medical devices, fast and easy LC-MS based detection methods for fungal infection biomarkers, and MOF based HPLC separations.

Innovator Technologies

A healthcare professional in blue scrubs and gloves draws a blood sample from a newborn in a neonatal incubator.

Self-Powered Medical Coatings That Generate Infection-Fighting Molecules

Hospital room with multiple patient beds and medical equipment.

Novel Antibacterial Surfaces

Nitric Oxide-Releasing Metal-Organic Frameworks: Novel Materials for Medical Device

Water droplet with reflection of building

Functionalization of Metal-Organic Frameworks with Controllable Wettability

Innovator Patents

US20190358618A1, US10406512B2, WO2015164821A1: Metal-organic framework functionalized polymeric compositions.

US20210169082A1, EP3651580A4, WO2019014348A1: Antibacterial surface of metal-organic framework-chitosan composite films.

WO2018191415A1, US20210114011A1: Functionalization of metal-organic frameworks.

US9034355B2, WO2012116177A3: Materials for modulating biological responses and methods of making.*

US10266408B2, US9493352B2, WO2011082164A1, EP2519467B1, US8771756B2: Modular biocompatible materials for medical devices and uses thereof.

US8034384B2, US8168423B2, US7335383B2: Method of increasing biocompatibility of medical device by generating nitric oxide.*

US7763283B2: Nitric oxide (NO) releasing material.

*Assignee other than Colorado State University.

Patent list generated using Google Patents.

Strata logo white
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
Serving the Colorado State University System with strategic real estate services, intellectual property protection and licensing, and financing activities.
Integrity
Reliability
Respect
Innovation
Excellence
Submit Disclosure

Newsletter Sign Up

Connect